Impacts of Climate Change Across the Cancer Control Continuum R01 Clinical Trial Optional
These funding opportunities aim to support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects. This includes, but is not limited to, studies to improve knowledge of the impact of climate change related environmental effects on cancer risks, control, and behaviors.
Additional Details
May 8 2026 Impacts of Climate Change Across the Cancer Control Continuum R21 Clinical Trial Optional
These funding opportunities aim to support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects. This includes, but is not limited to, studies to improve knowledge of the impact of climate change related environmental effects on cancer risks, control, and behaviors.
Additional Details
May 8 2026 Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population
Cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. DCCPS has several broad areas of interest: development and validation of methods, technologies, and tools in surveillance, statistics, epidemiology, health care delivery, and the behavioral sciences; identification of modifiable risk factors or host susceptibility factors associated with cancer etiology, cancer prevention, and treatment outcomes; and clinical and translational science to reduce risk, incidence, and death from cancer, as well as enhance the quality of life for cancer survivors.
Additional Details
Deadline: February 12, 2029; Rolling deadlines through 2029 Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
The focus of this research area is early translational research aimed at advancing the application of the mechanistic and scientific understanding of carcinogenesis and human biology towards interventions focused on cancer prevention, interception, screening, and early detection. These mechanistic understandings can be informed by research conducted across basic science, epidemiology, behavioral, or clinical studies and by varied scientific disciplines.
Additional Details
Deadline: February 12, 2029; Rolling deadlines through 2029 National Comprehensive Cancer Network (NCCN) Foundation Young Investigator Award (YIA)
The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation®each year announce new recipients for the NCCN Foundation Young Investigator Awards (YIA) Program. The honorees will receive up to $150,000 in funding, over two years, to advance important research on important issues in oncology. These early-career investigators from NCCN Member Institutions represent tomorrow’s leaders for advancing cancer care. The NCCN Oncology Research Program (ORP) manages the selection process and provides guidance and oversight for the projects over the grant duration.
Additional Details
Deadline: November 14, 2024
Robert J. Kleberg Jr. and Helen C. Kleberg Foundation Spring 2025 Medical Research Award
The Robert J. Kleberg Jr. and Helen C. Kleberg Foundation announces a funding opportunity to support a full-scale research project focused on a distinctive and novel approach(es), questioning prevailing paradigms and leading to the advancement of knowledge in the field of cancer research and clinical care. The Foundation seeks highly innovative and groundbreaking medical research proposals from Vanderbilt-Ingram Cancer Center in basic biological and applied research that will have the greatest impact on scientific knowledge and human health in cancer. The Foundation seeks to fund one full-scale proposal from Vanderbilt-Ingram Cancer Center in the amount of $1.5M over three years with a proposed project timeline of July 2025 to June 2028.
Additional Details
Deadline: December 6, 2024
|
